Why Your Body Destroys NAD+ Before It Can Use It (And the $5 Fix Nobody Talks About)

Your body cannot absorb NAD+ directly. That is the starting point for everything that follows, and it is also the reason a $5 bottle of niacin can outperform a $60 supplement if you understand what is actually happening at the cellular level.

NAD+ is a large molecule, and cell membranes do not let large molecules pass through freely. So when you take an NAD+ supplement, or receive it through an IV, your body has to break it down into smaller pieces first, carry those pieces into the cell, and then reassemble them into NAD+ on the inside. A 2019 pilot study confirmed this in a striking way: researchers infused 750 milligrams of NAD+ directly into people's veins and found that the molecule was completely degraded before it ever reached the cells. Every single milligram. The body stripped it apart in circulation and the pieces traveled the rest of the way on their own.

That is why supplementing with NAD+ directly does not work the way people imagine. But here is where it gets more interesting, because the same problem applies to NMN and NR, just for a slightly different reason.

NMN and NR are smaller molecules than NAD+, so they were developed as precursors, meaning your body uses them as raw materials to build NAD+ rather than trying to absorb NAD+ intact. NR can enter cells through specific transporters and then get assembled into NAD+ inside. NMN is one step further along the pathway, so it was assumed it could enter cells even more efficiently. But a 2016 study found that NMN cannot actually enter most mammalian cells directly. It first has to be converted into NR by an enzyme called CD73, which sits on the outside of the cell. Then it enters as NR. So whether you are taking NMN or NR, both of them funnel through NR as the entry point.

Once NR gets inside the cell, it enters what is called the salvage pathway, which is the cell's recycling system for NAD+ and its breakdown products. The salvage pathway is efficient under normal conditions. The problem is that it runs into a serious obstacle as you get older.

There is an enzyme called CD38, which is a protein that breaks down NAD+ as part of normal immune signaling. In young tissue, CD38 activity is moderate and the salvage pathway keeps up. But a 2016 study measuring CD38 across multiple tissues found that its activity increases two to three fold with age, and the correlation between rising CD38 and falling NAD+ levels is nearly perfect. The enzyme is essentially consuming NAD+ faster than the salvage pathway can replace it. You are trying to fill a bucket that has a larger and larger hole in the bottom.

This is the context you need to understand why niacin works differently, and potentially better.

Niacin, which is the form of vitamin B3 that causes a skin flush, enters NAD+ production through a completely separate route called the Preiss-Handler pathway. This pathway does not intersect with the salvage pathway until a much later step, which means it does not compete with CD38 at the same chokepoint. It is building NAD+ through a different door.

A 2020 study put this to a direct test in people with confirmed NAD+ deficiency caused by mitochondrial disease. Patients received 750 to 1000 milligrams of niacin per day for ten months. Blood NAD+ increased 2.3 times. Muscle NAD+ increased 1.3 times. Those participants also showed improvements in muscle strength and markers of mitochondrial biogenesis, meaning the cells were not just accumulating NAD+ but actually using it to regenerate mitochondria.

The 2.3 times increase in blood NAD+ is worth sitting with for a moment, because that is the range you see reported for NMN and NR in comparable studies, and niacin achieves it through a pathway that age-related CD38 elevation does not directly impair.

There is one more detail that makes the mechanism even more interesting. A 2019 study on NR supplementation in older adults found something unexpected: supplementing with NR caused increases in a molecule called NAAD, which is a Preiss-Handler pathway intermediate. The researchers found that some of the NR was being converted back into nicotinic acid in the body and entering through the Preiss-Handler pathway anyway. So even the expensive NR supplements are, in part, working by becoming niacin after the fact.

That is worth understanding clearly. You are paying for NMN or NR, and your body is partially converting it into the cheaper molecule to use the pathway that actually bypasses the problem.

On the practical side, niacin does produce a flush. In the first week or two, taking niacin causes a wave of skin redness and warmth that lasts roughly 20 to 30 minutes. This happens because niacin binds to receptors in skin cells and triggers a local release of prostaglandins, which dilate capillaries near the surface. It is a signaling response, not a side effect of toxicity, and it reliably diminishes over time as the receptor response downregulates. Taking niacin with food, or starting at a lower dose and building up, reduces the intensity.

Niacinamide, which is a different form of vitamin B3 with no flush, does not enter the Preiss-Handler pathway the same way. It goes through the salvage pathway like NMN and NR do. So the flush is not separable from the mechanism. The molecule that causes the flush is the molecule that uses the different door.

The deeper point here is about understanding what problem you are actually trying to solve. If NAD+ is declining because CD38 is accelerating its breakdown through the salvage pathway, then adding more precursors to that same pathway is partly running against the current. Niacin does not solve the CD38 problem either, but it routes around the traffic instead of fighting through it.

The body already built a second road. It was there the whole time.

---

References

1. Ratajczak J, Joffraud M, Trammell SAJ, et al. 2016. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nature Communications, 7:13103. Finding: NMN must be converted to NR by CD73 before cellular uptake, establishing NR as the common entry point for both NMN and NR supplementation. Source
2. Elhassan YS, Kluckova K, Fletcher RS, et al. 2019. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Reports, 287:1717-1728. Finding: NR supplementation produced significant increases in NAAD a Preiss-Handler pathway intermediate in human muscle, indicating NR partially converts to nicotinic acid in vivo. Source
3. Pirinen E, Auranen M, Khan NA, et al. 2020. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. Cell Metabolism, 316:1078-1090. Finding: Niacin 750-1000 mg/day raised blood NAD+ 2.3x and muscle NAD+ 1.3x in human subjects via the Preiss-Handler pathway, with concurrent improvements in muscle strength and mitochondrial biogenesis. Source
4. Grant R, Berg J, Mestayer R, et al. 2019. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Frontiers in Aging Neuroscience, 11:257. Finding: IV NAD+ 750 mg was rapidly and completely removed from plasma, with metabolites confirming full extracellular degradation before cellular uptake. Source
5. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. 2016. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metabolism, 236:1127-1139. Finding: CD38 activity increases 2-3 fold with age across tissues, with near-perfect inverse correlation to NAD+ levels. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness